Evidence map›Paper›PMID 41170179›Full record

ArticleDigital health

Dynamics of the atherogenic index of plasma and diabetes conversion: Insights from machine learning and longitudinal pattern analysis in middle-aged and older Chinese adults with prediabetes.

Zhan Chen, Yue Zhang, Liming Wang

Abstract read
In one paragraph

Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhan ChenDepartment of Vascular Surgery, Beijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital, Beijing, China.
Yue ZhangDepartment of Geriatrics, Beijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-8017-6596
Liming WangDepartment of Geriatrics, Beijing Sixth Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Atherogenic dyslipidemia significantly influences diabetes development, yet the longitudinal prognostic value of the atherogenic index of plasma (AIP) in prediabetic populations remains understudied. This study investigated whether dynamic AIP measures predict diabetes conversion in middle-aged and older Chinese adults with prediabetes while exploring interactions with other metabolic risk factors through interpretable machine learning. Methods: We analyzed data from 1965 prediabetic adults (≥ 45 years) from the China Health and Retirement Longitudinal Study (2012-2015), assessing baseline AIP, cumulative AIP exposure (AIPcum), and change patterns via K-means clustering. Associations with incident diabetes were evaluated using logistic regression with progressive confounder adjustment. Five machine learning models were developed using predictors identified through the Boruta algorithm and recursive feature elimination, with the best model interpreted via SHAP (SHapley Additive exPlanations) analysis. Results: During follow-up, 15.0% of participants progressed to diabetes. Elevated AIPcum showed the strongest association with diabetes risk (OR for highest vs. lowest quartile = 2.37; 95% CI: 1.60-3.57; Conclusion: Cumulative AIP exposure and unfavorable AIP change patterns independently predict prediabetes-to-diabetes progression. Incorporating these measures into risk assessment may enhance early identification of high-risk individuals and inform targeted interventions.

Indexed as

Atherogenic index of plasmacumulative exposurediabetesmachine learningprediabetesSHAP analysis

Identifiers

PMID41170179
PMCPMC12569368

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.